FDA-Cleared AI Directory

Ophthalmic AI Cleared by the FDA

Eye screening AI, including the first products cleared to give a result without a specialist reading the image.

This small field carries outsized importance, because it is where autonomous AI actually arrived in American medicine.

Diabetic retinopathy screening is the reason. The disease is common, it is silent until it is not, the screening image is standard, and there are nowhere near enough eye specialists to read every picture. That combination is what made regulators willing to clear software that returns a result on its own.

If you want to see what a fully autonomous clearance looks like in practice, including the conditions attached to it, this is the field to read.

Device Types in Ophthalmic

The FDA sorts cleared AI into named device types. Each one has its own bar to clear, so the type tells you what the product is allowed to claim.

FDA device types for AI in Ophthalmic
Device typeWhat it is allowed to doClearedLatest
Diabetic Retinopathy Detection AI Screens photographs of the back of the eye for diabetic damage, in some cases giving the result without a specialist reading it. 8 July 2, 2026

Newest Ophthalmic Clearances

Most recent clearances in Ophthalmic
ProductCompanyClearedFDA record
iPredict-DR iHealthscreen, Inc. July 2, 2026 K253704
AEYE-DS Aeye Health, Inc. April 23, 2024 K240058
EyeArt v2.2.0 Eyenuk, Inc. June 16, 2023 K223357
AEYE-DS Aeye Health, Inc. November 10, 2022 K221183
IDx-DR v2.3 Digital Diagnostics, Inc. June 17, 2022 K213037
IDx-DR Digital Diagnostics, Inc. June 10, 2021 K203629
EyeArt Eyenuk, Inc. August 3, 2020 K200667
IDx-DR Idx, LLC April 11, 2018 DEN180001

Clearance data comes from the FDA's public 510(k) and device classification records through openFDA. A clearance is a regulatory decision about a product, not a recommendation, and it does not measure how well the product works in your own setting. Confirm the current status and the exact cleared indication on the FDA record before you buy.